Search
Amarin Corporation PLC
AMRNAdd to Watchlist
14.260USD
+0.030+0.21%
Close 07-31 16:00（ET）Quotes delayed by 15 min
301.21MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Amarin Corporation PLC is 5.00, ranking 339 out of 385 in the Biotechnology & Medical Research industry. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
Analyst Rating
Based on
1
analysts
Sell
Current Rating
12.000
Target Price
-26.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Amarin Corporation PLC
AMRN
1
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Amarin Corporation PLC's expected revenue for the next quarter?
Amarin Corporation PLC's expected revenue is 41.42M.
What is Amarin Corporation PLC's price target?
Analysts forecast that Amarin Corporation PLC's price target is USD 12.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 12.00.
What is the analyst rating for Amarin Corporation PLC?
Based on the ratings of Amarin Corporation PLC's stock from 1 analysts, most analysts support a Sell trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Sell. Please note that this is not trading advice. You still need to conduct your own analysis.